Prostate Cancer
Clinical Trials

1) First Line Metastatic mCRPC: USO #19191: BMS CA209-7DX: A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (Check-Mate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX)

2) Cohort 21 and 23 part of XL184-021 EXELIXIS: A Phase Ib Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors (More information under Prostate Cancer/Solid Tumors Section)

Send UsA Message

    Jenny’s Journey Reflects Our Mission

    Jenny’s Journey Reflects Our Mission

    At Charleston Oncology, the mission of healing all people with compassion, faith and excellence resonates through the hallways and translates into every patient interaction.

    read more
    Myra Walks in a Patient’s Shoes

    Myra Walks in a Patient’s Shoes

    In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.

    read more
    Call Now Button